Project Details
Description
Discovery and development of allosteric inhibitors of Cdk2/cyclin E as non-toxic ovarian cancer drugs
| Status | Active |
|---|---|
| Effective start/end date | 7/1/23 → 12/31/24 |
Funding
- MN OVARIAN CANCER ALLIANCE
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.